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ABSTRACT
Flurbiprofen, a potent nonsteroidal anti-inflammatory drug, is widely used for relief of pain in patients 
suffering from rheumatic diseases, migraine, sore throat and primary dysmenorrheal. However, this 
drug has many gastrointestinal side effects produced by its oral administration, such as gastric bleeding 
and peptic ulcer. These effects were responsible for non-compliance among patients, which ultimately 
results in treatment failure. The physicochemical properties of flurbiprofen, make it a suitable candidate 
for transdermal drug delivery, which can overcome the drawbacks of oral administration. In this sense, 
microemulsions have been proved to increase the cutaneous absorption of lipophilic drugs when compared 
to conventional drug delivery systems. The purpose of this study was to formulate and characterize gel 
based microemulsions, for topical delivery of flurbiprofen. Different gel bases, containing microemulsion 
and hydro-alcoholic solution of flurbiprofen, were developed and compared. In vitro study showed 
that gels containing microemulsion had a higher permeation rate than those containing hydro-alcoholic 
solutions. Additionally, formulation of Carbopol-I (microemulsion) showed higher percent of inhibition 
of inflammation than others bases. Further, skin irritation study demonstrated that Carbopol-I was none 
irritating. Flurbiprofen microemulsion incorporated on Carbopol-I showed physicochemical, in vitro and 
in vivo characteristics suitable for the development of alternative transdermal delivery formulation.




Flurbiprofen is used in inflammation, rheumatic 
diseases and mild to moderate pain of migraine, 
sore throat and also in primary dysmenorrheal 
(British National Formulary 2006, Schachtel et al. 
2014). Many gastrointestinal side effects caused 
due to the presence of free carboxylic acid group 
(Figure 1), are produced by its oral administration, 
such as dyspepsia, cramping, gastric bleeding 
and peptic ulcer, causing non-compliance among 
patients, which ultimately results in treatment 
failure (Mishra et al. 2008).
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The physicochemical properties of flurbiprofen, 
i.e., lipophilicity, low molecular weight and short 
elimination half-life make it a suitable candidate for 
transdermal drug delivery, which can overcome the 
drawbacks of oral administration (Fang et al. 2003). 
However, it’s very low aqueous solubility hinders 
the skin permeation. Thus, it is imperative to develop 
novel drug delivery systems aimed to improve its 
skin permeation and therapeutic compliance.
In this sense, microemulsions have been 
proven to increase the cutaneous absorption of 
lipophilic drugs when compared to conventional 
vehicles (Nisha et al. 2011). Microemulsions are 
fluid, transparent, thermodynamically stable oil and 
water systems, stabilized by a surfactant usually 
in conjunction with a cosurfactant that could be 
a short-chain alcohol, amine, or other weakly 
amphiphilic molecule. An interesting characteristic 
of microemulsions is that the diameter of the 
droplets is in the range of 100–1000 A°, whereas 
the diameter of droplets in a kinetically stable 
macroemulsion is 5000 A°. The small droplet size 
allows the microemulsion to act as carriers for 
drugs that are poorly soluble in water (Zhu et al. 
2009). The suggested method of preparation of 
microemulsions is as follows: the surfactant, oil 
and water are mixed, to form a milky emulsion, and 
titrated with a fourth component, the co-surfactant, 
until the mixture becomes clear. If more oil is added 
to a water/oil (w/o) system, the system becomes 
cloudy, but the addition of more co-surfactant again 
gives a clean transparent emulsion (Betageri and 
Prabhu 2007, Fouad et al. 2013).
In the present study, the polymer based gel 
containing microemulsion or hydro-alcoholic 
solution were formulated using Carbopol 934P 
and Xanthan gum as gelling agents and were 
characterized on the basis of pH, viscosity, 
conductivity and thermodynamic stability study. 
In vitro permeation through excised rabbit skin 
and in vivo anti-inflammatory activity were also 
investigated. Furthermore 934P based gel containing 
microemulsion was evaluated for skin irritation.
MATERIALS AND METHODS
The following materials were received and 
used: Flurbiprofen (Hamaz, Pakistan), Oleic 
acid (Merck, Germany), Tween 20 (Fisher 
Scientific, UK) Propylene glycol (Merck, 
Germany), Ethanol (Merck, Germany), Potassium 
dihydrogen orthophosphate (Merck, Germany), 
Sodium hydroxide pellets (Merck, Germany), 
Xanthan Gum (CCL Lahore), Carbopol 934P 
(Wilson, Islamabad), Triethanol amine (Merck, 
Germany), Methyl and Propyl paraben (Merck, 
Germany), Water Soluble Tetrazolium-1 (Dojindo 
Laboratories, Kumamoto, Japan), Zymosan A 
(Sigma Chemicals, St Louis, MO, USA).
PREPERATION OF MICROEMULSION AND HYDRO-ALCOHOLIC 
SOLUTION OF FLURBIPROFEN
Flurbiprofen loaded microemulsion obtained by a 
simplex lattice experiment design in our previous 
study was comprised of 5% (w/w) flurbiprofen, 
5% (w/w) oleic acid, 46% (w/w) Tween 20:ethanol 
(2:1) and 44% (w/w) water (Idress et al. 2011). 
The preparation method was as follows, Oil and 
Smix (surfactant + cosurfactant, 2:1) were mixed 
vigorously under constant stirring. A known 
amount of flurbiprofen was added to this oily 
phase and mixed until completely dissolved. 
Then an appropriate amount of distilled water 
was added slowly under constant stirring at room 
temperature. The microemulsions were stored at 
room temperature (Chen et al. 2006).
Figure 1 - Chemical Structure of Flurbiprofen.
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For hydro-alcoholic solution, flurbiprofen 
was dissolved in ethanol and mixed well until 
completely dissolved. Then distilled water was 
added in alcoholic drug solution to form hydro-
alcoholic solution under gentle mixing.
PREPERATION OF CARBOPOL AND XANTHAN GUM BASED 
GELS CONTAINING MICROEMULSION AND HYDRO-ALCOHOLIC 
SOLUTION
The first step consisted of Carbopol gel bases 
containing 0.70, 0.80, 0.90, 1.00, 1.10 and 1.20% 
w/w were prepared by gradually dissolving Carbopol 
934P in specific amounts of distilled water, at room 
temperature, under constant stirring. Triethanol 
amine was added to adjust the pH between 6 to 7. 
From the different bases, that containing Carbopol 
1% (w/w) was found to have optimum viscosity and 
was thus selected for further studies.
Xanthan gel bases containing 1.10, 1.20, 1.30, 
1.40, 1.50 and 1.60% were prepared by first dissolving 
the gum in specific amounts of distilled water at room 
temperature under constant stirring. The methyl and 
propyl paraben were then added as preservatives. 
From the different bases, those containing 1% (w/w) 
and 1.5% (w/w) of Carbopol 934P and Xanthan gum 
respectively, were found to have optimum viscosity 
and selected for further studies.
 In second step microemulsion or hydro-
alcoholic solution of flurbiprofen were added 
separately to the 1% (w/w) Carbopol 934P and 
1.5% (w/w) Xanthan gum to make Carbopol 934P 
and Xanthan gum based gels and mixing was done 
at room temperature.
CHARACTERIZATION OF GEL BASES AND MICROEMULSION
Brookfield RVDV III ultra, Programmable 
Rheometer (Brookfield Engineering Laboratories, 
Middleboro, MA) was used to determine the 
viscosities by using ULA (Ultra Low Adaptor) 
under a temperature of 25 °C. Conductometer 
WTW Cond 197i (Weilhein, Germany) was used to 
determine the conductivities (σ) under a temperature 
of 25 °C (Djordjevic et al. 2005). pH meter (WTW 
inolab, Germany) was used to measure the pH 
values under a temperature of 25 °C. The analyses 
were performed in triplicate.
THERMODYNAMIC STABILITY TESTS
The selected formulations of Carbopol and Xanthan 
were kept for 3 months at 40 °C and centrifuged at 
10,000 rpm for 15 min to check physical stability. 
Furthermore, these formulations were also 
evaluated at 25 °C for pH changes, visual clarity, 
viscosity, conductivity and assessment of drug 
using UV assay.
IN VITRO SKIN PERMEATION RELEASE RATE
Skin samples were obtained from the dorsal region 
of rabbit after removing hair with razor (Chen et al. 
2006). Heat separation was used to remove epidermis 
and scalpel was used to remove subcutaneous fat 
(Shah et al. 2006, Pellet et al. 1997). Diffusion cells 
of Vertical Franz type (PermeGear, Bethlehem, PA) 
were used with diffusional surface area of 1.767 
cm2. The receptor compartment, with capacity of 12 
ml, contained the phosphate buffer solution (PBS) 
at 7.4 pH. The skin was placed between the donor 
and receptor compartments of the cell (Ozguney et 
al. 2006). Water bath and a peristaltic pump were 
used to maintain the temperature of the receptor 
solution at 37° C. Teflon-coated magnet bar was 
used for stirring. The concentration of the selected 
formulations was 1.0 g that was applied to donor 
compartment. After pre-determined time intervals 
(0 to 24 hours), 1ml of the sample was removed from 
the receptor compartment for UV determination 
and immediately replaced with an equal quantity 
of fresh PBS. There was no interference of the 
components. These dose conditions are infinite 
(Roessler et al. 2001).
The cumulative amount of flurbiprofen was 
plotted as a function of time through excised rabbit 
skin. The permeation release rate of flurbiprofen 
was calculated from the slope and intercept of the 
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straight line by plotting the amount of flurbiprofen 
permeated versus the time in steady state conditions. 
Permeation coefficient was calculated by dividing 
the flux by the flurbiprofen concentration of the 
donor compartment.
ANTI-INFLAMMATORY ACTIVITY ASSAY
The method for the isolation of human neutrophils 
was established (Kantarci et al. 2007). The anti-
inflammatory activity of polymer based gel 
formulations was assayed (Siddiqui et al. 1995). 
In this in vitro study, Opsonised Zymosan A was 
used to activate the neutrophils. These activated 
neutrophils were used for the reduction of water 
soluble tetrazolium salt. The anti-inflammatory 
activity was determined by using Carbopol and 
Xanthan gum based gels containing microemulsion 
or hydro-alcoholic solution, water soluble 
tetrazolium salt in concentration of 250 µm and 
Modified Hank’s Solution (MHS) of pH 7.4 
in concentration of 200 µl containing 1.0-104 
neutrophils/ml. The control consisted of water 
soluble tetrazolium salt, buffer and neutrophils. 
The Opsonised Zymosan A (15mg/ml) was added 
to initiate a reaction of test compounds. Absorbance 
was taken at 450 nm. The formula for percent of 
inhibition is given below. The software used was 
EZ-FIT Windows-based software.
% Inhibition = 100 - {(Optical density of 
formulation / Optical density of control) ×100}.
IN VIVO SKIN IRRITATION STUDY
The screened Carbopol 934P based gel containing 
microemulsion was applied to the inner arms of 10 
human volunteers aged between 21-27 years, by 
placing gel on gauze dressing (1×1 cm2). Stretch 
adhesive tape was used for fixing the gel on the inner 
arm. The reading was taken after 8 h (OECD 2004).
STATISTICAL ANALYSIS
Two-way analysis of variance (ANOVA) was used 
to measure the skin permeation release rate. For 
the study of skin irritation, statistical paired sample 
t-test was used at the level of P = 0.05. These tests 
were performed by SPSS 12.0 software.
ETHICAL STANDARDS
Ethical approval for different bases containing 
flurbiprofen microemulsion studies was granted 
by the Islamia University of Bahawalpur, Pakistan 
and Institutional ethical committee. The informed 
consent was filled by the patients before the test.
RESULTS
CHARACTERIZATION OF GEL BASES AND MICROEMULSION
A number of gel bases were prepared by using 
different concentrations of Carbopol 934P and 
Xanthan gum. The viscosities of Carbopol 934P 
(0.70-1.20% w/w) and Xanthan gum (1.10-1.60% 
w/w) gel bases were in the range of 307-1522 cp 
and 151-460 cp respectively. The conductivities 
of Carbopol 934P (0.70-1.20% w/w) and Xanthan 
gum (1.10-1.60% w/w) gel bases were in the 
range of 322-1293 and 405-1360 microsiemens/
cm respectively. The pH values of Carbopol 934P 
(0.70-1.20% w/w) and Xanthan gum (1.10-1.60% 
w/w) gel bases were in the range of 6.00-6.11 and 
6.13-6.25 respectively. The Carbopol 934P and 
Xanthan gum gel bases of 0.7% and 1.10% (w/w) 
respectively had high fluidity while the Carbopol 
934P and Xanthan gum gel bases of 1.20% and 
1.60% (w/w) respectively had high viscosity.
THERMODYNAMIC STABILITY STUDY
As the Carbopol 934P and Xanthan gum gel bases 
of 1.00% and 1.50% respectively had suitable 
fluidity and viscosity therefore, these were selected 
for further studies. Stability study showed that 
the selected gel bases containing microemulsion 
(Carbopol-I and Xanthan-I) and gel bases 
containing hydro-alcoholic solution (Carbopol-
II and Xanthan-II) were physically stable. The 
formulations were stable at 40° C and no phase 
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separation and degradation of flurbiprofen were 
observed during the 3 months study. The viscosity, 
conductivity and pH of these gel formulations and 
the microemulsion after thermodynamic stability 
test are shown in Table I.
IN VITRO PERMEATION SKIN RELEASE STUDY
The cumulative amount of flurbiprofen after 24 h 
of applying microemulsion, Carbopol-I, Xanthan-I, 
Carbopol-II and Xanthan-II was 572.01, 476.40, 
436.62, 135.59 and 132.61 µg/cm2 respectively. The 
in vitro skin permeation showed a steady increase 
in concentration of flurbiprofen in the receptor 
chamber with time (Figure 2). The permeation 
release rate was highest for microemulsion and 
lowest for both Carbopol-II and Xanthan-II.
The transdermal flux was calculated from 
permeation release rate and the permeation coeffi cient 
was calculated from transdermal flux values. Then 
the results were analyzed by two-way ANOVA with 
level of significance of 0.05. The transdermal flux of 
microemulsion, Carbopol-I, Xanthan-I, Carbopol-
II and Xanthan-II was 18.75, 15.72, 9.80, 4.76 and 
2.70 µg/cm2/h respectively after 24 hour. In the same 
way, the permeability coefficient of microemulsion, 
Carbopol-I, Xanthan-I, Carbapol-II and Xanthan-
II was 0.38, 0.31, 0.19, 0.09 and 0.05 µg/cm2/h 
respectively after 24 h (Table II).
Sr. No. Formulation Code Viscosity (cp) Conductivity (σ) (µS/cm) pH
1 Carbopol-I 400 387 6.09
2 Xanthan-I 280 485 6.16
3 Carbopol-II 270 470 6.05
4 Xanthan-II 190 655 6.15
5 Microemulsion 55 145.5 5.01
TABLE I
Physicochemical parameters of microemulsions, Carbopol 934P and 
Xanthan gum based gels containing microemulsions and hydro-alcoholic 
solution after 3 months at 40 °C. All measurements were done at 25 °C. 
Figure 2 - Comparison of Permeation profile of Flurbiprofen through excised rabbit skin of Microemulsion 
and; Carbopol 934P and Xanthan gum based gel containing microemulsion and hydro-alcoholic solution. 
Mean ± S.D. (n = 3).
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TABLE II
Permeation parameters of Carbopol 934P and Xanthan 
Gum based gels containing microemulsions and hydro-
alcoholic solutions. Mean ± S.D. (n = 3).
Sr. No. Formulation Codes Flux, Jss (µg/cm2/h) Permeability CoefficientKp × 10-3 (cm/h)
1 Carbopol-I 15.72±0.05 0.31±0.041
2 Xanthan-I 9.80±0.09 0.19±0.017
3 Carbopol-II 4.76±0.07 0.09±0.011
4 Xanthan-II 2.70±0.05 0.05±0.007
5 Microemulsion 18.75±0.08 0.38±0.045
The permeation release rate of microemulsion, 
Carbopol-I, Xanthan-I, Carbopol-II and Xanthan-II 
were measured by two-way ANOVA with level 
of significance of 0.05 and the measured value of 
P was less than 0.05.
ANTI-INFLAMMATORY STUDY
The results of anti-inflammatory study of 
Carbopol-I, Xanthan-I, Carbopol-II and Xanthan-II 
are given in Table III. The percent of inhibition of 
inflammation was highest for gel bases containing 
the microemulsion and lowest for both containing 
hydro-alcoholic solution.
IN VIVO SKIN IRRITATION STUDY
Erythema values before and after the application of 
Carbopol-I were noted and are given in Table IV. 
Statistical pair sample t-test was used to analyze 
the results, with level of significance of 0.05 and 
p=0.05. No significant increase in erythema values 
was observed after 8 h of application.
DISCUSSION
Carbopol 934P and Xanthan gum was used to 
prepare gel bases in different concentrations. In 
preparing gels, the color of the final formulation 
was turned white. This was caused by dehydration 
of some of the ingredients like surfactant and co-
surfactant of microemulsion, which results in 
dissociation of polymers from hydrated state.
Incorporation of polymers into microemulsion 
and addition of microemulsion into the gel bases 
were used to formulate polymer based gel. In direct 
addition of polymer to the microemulsion, more 
time was consumed for the swelling of polymer. 
A non-homogeneous gel containing microemulsion 
was formed due to incomplete swelling of polymer 
and formation of small agglomerates. The gel base 
was first prepared in which the whole amount of 
polymer was completely swelled in aqueous phase. 
TABLE III
Percent of inhibition of inflammation of polymer 
based gel containing microemulsion (Carbopol-I and 
Xanthan-I) and hydro-alcoholic solution of flurbiprofen 
(Carbopol-II and Xanthan-II).
S. No Formulations % Inhibition
1 Carbopol-I  57
2 Xanthan-I  45
3 Carbopol-II  25
4 Xanthan-II  15
TABLE IV
Erythema values before (control) and after the 
application of Carbopol-I on 10 human volunteers.
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The known amount of microemulsion was mixed 
gradually into the gel base. Complete swelling with 
no agglomerates was observed due to complete 
swelling of polymer (Tan and Berridge 2000).
The Carbopol 934P and Xanthan gum gel bases 
of 1.00 and 1.50% (w/w) respectively had suitable 
fluidity and viscosity for the topical delivery 
system. Thus, these gel bases were used for the 
preparation of gels containing microemulsion 
or hydro-alcoholic solution of flurbiprofen. The 
high conductivity indicated Oil/Water (O/W) 
microemulsion and the pH values near 7 could be 
resulted in less irritation to skin. The intracellular 
and transcellular micropathways play a vital 
role in the permeation of drug through stratum 
corneum. The intracellular pathway has higher 
percutaneous absorption than that of transcellular. 
The physicochemical properties of microemulsion 
and stratum corneum were studied to check the 
permeability enhancing ability of microemulsion 
and efficiency for percutaneous absorption. The 
polar and lipid pathways are changed when oily 
phase of microemulsion containing drug enter the 
stratum corneum of the skin. The oily phase of 
microemulsion can interact with skin in a number of 
ways. The oily phase of microemulsion containing 
drug can directly partition into the lipids of stratum 
corneum. This changes the bilayer structure of skin. 
The intracellular volume of stratum corneum can 
be increased by the oily phase of microemulsion, 
which in turn changes the interfacial structure. The 
permeation of hydrophobic drug can be increased 
by disruption of lipid layers caused by swelling of 
proteins (Chen et al. 2007).
Carbopol-I showed intermediate permeation 
release rate between microemulsion and Xanthan-I. 
Release rate of microemulsion is higher than 
Carbopol-I which is due to the presence of oleic 
acid and ethanol in microemulsion. This in turn 
reduce the barrier function of the stratum corneum 
and enhance the permeability coefficient of 
flurbiprofen through skin. The results showed that 
the addition of polymer to microemulsion decrease 
the permeability of flurbiprofen by increasing the 
viscosity and transform from microemulsion to the 
lamellar structure or a highly ordered microstructure 
(Hire et al. 2007, Trotta 1999, Peltota et al. 2003). 
Additionally, the permeation release rate of 
microemulsion, Carbopol-I, Xanthan-I, Carbopol-
II and Xanthan-II showed that the transdermal flux 
of these formulations are significantly different 
from each other (ANOVA, P<0.05). It is clear from 
all the formulations that the transdermal flux of 
microemulsion and polymer based gels containing 
microemulsion was greater than that of polymer 
based gels containing hydro-alcoholic solution.
In relation to anti-inflammatory study, a 
significant increase in the percent of inhibition of 
inflammation was observed for gel bases containing 
microemulsion (Carbopol-I and Xanthan-I) as 
compared to gel bases containing hydro-alcoholic 
solution (Carbopol-II and Xanthan-II). Moreover, 
droplet sizes of microemulsion used in both 
Carbopol-I and Xanthan-I was smaller and thus 
provides more opportunities for drug transferring 
into the skin improving its transdermal flux and 
pharmacologic activity (Khurana et al. 2013, Okur 
et al. 2014).
Although microemulsion had higher permeation 
release rate, but its use is limited due to having 
low pH which might produce skin irritation 
and comparatively less adherence to the skin. 
Therefore, adherence and pH of microemulsion 
could be increased by incorporation of Carbopol 
934P. Therefore, the formed Carbopol 934P based 
gel containing microemulsion (Carbopol-I) had 
pH in the range of 6-7 which is non-irritating and 
more adhering to the skin to produce intermediate 
permeation release rate with sustained effect. 
Carbopol-I had higher transdermal flux and percent 
of inhibition of inflammation as compared to 
Xanthan-I. Consequently, Carbopol-I was finally 
selected for in vivo skin irritation study. No 
significant difference in the values of erythema 
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before and after the application of Carbopol-I was 
observed. Moreover, no apparent change on the 
surface of the skin (t-test, p=0.05) was noticed that 
confirmed non-irritating effect of Carbopol-I to the 
skin of all volunteers.
CONCLUSIONS
The present study showed that Carbopol 934P 
based gel containing microemulsion of flurbiprofen 
had optimum thermodynamic stability, potential 
for in vitro permeation release rate and inhibition 
of inflammation. These properties can facilitate 
development of a cutting-edge strategy for trans-
dermal delivery of flurbiprofen using innovative 
formulations of polymer based gel containing 
microemulsion.
RESUMO
O flurbiprofeno, potente anti-inflamatório não esteroidal, 
é amplamente utilizado no alívio da dor de pacientes 
que possuem doenças reumáticas, enxaqueca, dores de 
garganta e dismenorreia primária. Entretanto, apresenta 
muitos efeitos gastrointestinais indesejáveis quando 
administrado por via oral como hemorragia gástrica 
e úlcera péptica. Esses efeitos foram responsáveis 
por baixa adesão entre os pacientes, o que resulta no 
comprometimento do tratamento. As propriedades 
físico-químicas do flurbiprofeno fazem dele um 
candidato promissor para a administração transdérmica, 
que pode eliminar os inconvenientes causados durante 
a administração oral. Neste sentido, provou-se que 
as microemulsões aumentam a absorção cutânea de 
fármacos lipofílicos quando comparadas aos sistemas 
de liberação convencionais. O objetivo desse estudo 
foi desenvolver e caracterizar géis bases contendo 
microemulsões de flurbiprofeno. Diferentes géis bases 
contendo microemulsão e solução hidroalcoólica de 
flurbiprofeno foram desenvolvidos e comparados. 
Os estudos in vitro indicaram que os géis contendo 
microemulsão apresentaram velocidade de permeação 
superior ao géis contendo as soluções hidroalcoólicas. 
Adicionalmente, a formulação de Carbopol -I 
(microemulsão) apresentou maior capacidade de 
inibição da inflamação em relação às outras bases. 
Além disso, o estudo demonstrou que formulação de 
Carbopol -I (microemulsão) não ocasionou irritações 
cutâneas. Desta forma, o gel base de Carbopol -I 
contendo microemulsão de flurbiprofeno apresentou 
características físico-químicas, desempenho in vitro e in 
vivo adequados para o desenvolvimento de formulação 
alternativas de liberação transdérmica.
Palavras-chave: estudo de ação anti-inflamatória, 
flurbiprofeno, géis, permeação In vitro, microemulsões.
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